David N. Standring
David N. Standring publishes mostly in Epidemiology, Hepatology and Infectious Diseases, on topics such as Hepatitis C virus research, Hepatitis B Virus Studies and HIV/AIDS drug development and treatment.
- World rank
- #870,160 of 7,710,434 ranked researchers
- Rank in United States
- #287,895 of 1,627,098
- Works
- 79
- Citations
- 4.6k
- Citations per work
- 57.9
What does David N. Standring research?
David N. Standring's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4455.9%
- Medicine4455.9%
- Everything else2024.9%
- Life Sciences1215.3%
- Physical Sciences33.9%
- Chemistry33.9%
- 1Epidemiology23% of their works
- 2Hepatology20% of their works
- 3Infectious Diseases14% of their works
- 4Molecular Biology11% of their works
- 5Virology4% of their works
- 6Organic Chemistry4% of their works
Research topics
Which keywords describe David N. Standring's research?
The keywords of their largest research topics: Immune Response, Antiviral Therapy, Liver Disease, Hepatitis C Virus, Treatment, Chronic Hepatitis B, Hepatitis B Virus and Antiretroviral Therapy.
- siRNA Delivery
- Therapeutic Antibodies
- Nucleotide Metabolism
- Virus
- HIV
- HIV Infection
- Antiretroviral Therapy
- Chronic Hepatitis B
- Hepatitis C Virus
- Antiviral Therapy
- Immune Response
- Liver Disease
- Treatment
- Hepatitis B Virus
- Drug Resistance
- AIDS
- Ecology
- Enzyme Regulation
- Fc Receptors
- RNA Interference
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Immune Response963 topics
- Antiviral Therapy862 topics
- Liver Disease862 topics
- Hepatitis C Virus441 topic
- Treatment441 topic
- Chronic Hepatitis B421 topic
- Hepatitis B Virus421 topic
- Antiretroviral Therapy352 topics
- Drug Resistance251 topic
- HIV Infection251 topic
- AIDS101 topic
- HIV101 topic
- Ecology91 topic
- Virus91 topic
- Enzyme Regulation81 topic
- Nucleotide Metabolism81 topic
- Fc Receptors71 topic
- Therapeutic Antibodies71 topic
- RNA Interference51 topic
- siRNA Delivery51 topic
Where does David N. Standring work?
David N. Standring's main affiliation in the publication record is Idera Pharmaceuticals (United States), United States.
How many publications and citations does David N. Standring have?
OpenAlex counts 79 works and 4,575 citations for David N. Standring, an h-index of 33, ranking #870,160 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David N. Standring. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.